News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
34,598 Results
Type
Article (2545)
Company Profile (18)
Press Release (32035)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (6648)
Career Advice (1482)
Deals (914)
Drug Delivery (2)
Drug Development (1314)
Employer Resources (35)
FDA (332)
Job Trends (616)
News (9572)
Policy (587)
Tag
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (175)
Accelerated approval (12)
ADA (6)
Allergies (30)
Alliances (1662)
ALS (64)
Alzheimer's disease (189)
Antibody-drug conjugate (ADC) (174)
Approvals (616)
Artificial intelligence (304)
ASCO (78)
Autoimmune disease (99)
Automation (28)
Bankruptcy (9)
Best Places to Work (597)
BIO (21)
Biologics (3)
Biosimilars (72)
BioSpace Insights (9)
Biotechnology (9)
Bladder cancer (117)
Brain cancer (11)
Breast cancer (287)
Cancer (1968)
Cardiovascular disease (142)
Career advice (1161)
Career pathing (18)
CAR-T (71)
CDC (3)
CDMO (9)
Cell therapy (222)
Cervical cancer (23)
Clinical research (3284)
Collaboration (832)
Commercialization (1)
Company closure (1)
Compensation (517)
Complete response letters (10)
COVID-19 (92)
CRISPR (40)
C-suite (477)
Cystic fibrosis (45)
Data (2334)
Decentralized trials (1)
Denatured (3)
Depression (31)
Dermatology (43)
Diabetes (100)
Diagnostics (508)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (133)
Drug pricing (9)
Drug shortages (4)
Duchenne muscular dystrophy (75)
Earnings (3174)
Editorial (5)
Employer branding (4)
Employer resources (31)
Events (5249)
Executive appointments (486)
FDA (1517)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (624)
Gene editing (77)
Generative AI (17)
Gene therapy (171)
GLP-1 (99)
Government (174)
Grass and pollen (3)
Guidances (112)
Healthcare (803)
Hematology (44)
HIV (53)
Huntington's disease (13)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (28)
Immunology and inflammation (29)
Immuno-oncology (28)
Indications (63)
Infectious disease (176)
Inflammatory bowel disease (40)
Inflation Reduction Act (2)
Influenza (22)
Intellectual property (59)
Interviews (271)
IPO (723)
Job creations (180)
Job search strategy (989)
JPM (5)
Kidney cancer (11)
Labor market (33)
Layoffs (44)
Leadership (12)
Legal (151)
Licensing (6)
Liver cancer (25)
Longevity (7)
Lung cancer (285)
Lymphoma (147)
Machine learning (26)
Management (7)
Manufacturing (276)
Marketing (7)
MASH (29)
Medical affairs (1)
Medical device (523)
Medtech (575)
Mergers & acquisitions (651)
Metabolic disorders (206)
mRNA (30)
Multiple sclerosis (39)
Neurodegenerative disease (127)
Neuropsychiatric disorders (23)
Neuroscience (604)
NextGen: Class of 2026 (380)
Non-profit (300)
Now hiring (20)
Obesity (67)
Opinion (42)
Ovarian cancer (67)
Pain (44)
Pancreatic cancer (58)
Parkinson's disease (94)
Partnered (2)
Patents (111)
Patient recruitment (254)
Peanut (10)
People (4422)
Peptides (1)
Pharmaceutical (8)
Pharmacy benefit managers (3)
Phase 1 (998)
Phase 2 (1266)
Phase 3 (1254)
Pipeline (2824)
Policy (13)
Postmarket research (45)
Preclinical (459)
Press Release (1)
Prostate cancer (123)
Psychedelics (1)
Radiopharmaceuticals (34)
Rare diseases (295)
Real estate (150)
Recruiting (22)
Regulatory (1521)
Reports (12)
Research institute (193)
Resumes & cover letters (329)
Rett syndrome (32)
RNA editing (3)
RSV (29)
Schizophrenia (44)
Series A (102)
Series B (89)
Sickle cell disease (27)
Special edition (4)
Spinal muscular atrophy (22)
Sponsored (3)
Startups (121)
Stomach cancer (1)
Supply chain (35)
Tariffs (2)
Vaccines (119)
Venture capital (18)
Weight loss (24)
Women's health (35)
Worklife (7)
Date
Today (53)
Last 7 days (121)
Last 30 days (528)
Last 365 days (7878)
2026 (5494)
2025 (8267)
2024 (3585)
2023 (922)
2022 (1178)
2021 (1332)
2020 (1599)
2019 (1767)
2018 (1136)
2017 (869)
2016 (888)
2015 (866)
2014 (711)
2013 (676)
2012 (767)
2011 (800)
2010 (583)
Location
Africa (129)
Alabama (7)
Arizona (26)
Arkansas (4)
Asia (1628)
Australia (304)
California (4561)
Canada (662)
China (250)
Colorado (141)
Connecticut (199)
Delaware (262)
Europe (5137)
Florida (357)
Georgia (67)
Hawaii (4)
Idaho (6)
Illinois (413)
India (27)
Indiana (52)
Iowa (11)
Japan (322)
Kansas (6)
Kentucky (8)
Louisiana (12)
Maine (4)
Maryland (324)
Massachusetts (3255)
Michigan (72)
Minnesota (174)
Missouri (49)
Nebraska (2)
Nevada (56)
New Hampshire (11)
New Jersey (1012)
New Mexico (8)
New York (906)
North Carolina (368)
North Dakota (3)
Northern California (2248)
Ohio (142)
Oklahoma (8)
Oregon (10)
Pennsylvania (411)
Puerto Rico (4)
Rhode Island (11)
South America (140)
South Carolina (7)
Southern California (1768)
Tennessee (73)
Texas (734)
United States (13844)
Utah (63)
Virginia (136)
Washington D.C. (17)
Washington State (323)
West Virginia (1)
Wisconsin (114)
34,598 Results for "eq search".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Opinion: The life sciences executive search crisis: When ‘cutting to the bone’ backfires
The 2022 search approach is no longer working. Companies need to think critically about how they are acquiring top regulatory, clinical and commercial executives or risk their programs in this new regulatory and market reality.
July 1, 2026
·
6 min read
·
Emma Morris
Job Trends
The long wait: biopharma job searches often take at least 6 months,
BioSpace
finds
More than half of biotech and pharma job seekers have been looking for their next opportunity for six months or longer, and more than a quarter have searched for over a year, according to a
BioSpace
LinkedIn poll. Job seekers share their frustrations.
May 28, 2026
·
3 min read
·
Angela Gabriel
Job Trends
Nearly 1/4 dealing with long-term unemployment call it quits on biopharma job searches
Limited opportunities and burnout are just two reasons biopharma professionals stop looking for work, with some pivoting away from the industry or turning to consulting. Two career coaches discuss why ending a job hunt is harmful and what to do instead.
August 27, 2026
·
6 min read
·
Angela Gabriel
Career Advice
Standing out, not blending in: how AI tools can drive impact during job searches
AI tools can help job seekers write resumes and mass apply to open positions, but those aren’t the only, or best, ways to use them. A career coach shares how she advises clients to make the most of AI during the application and interview process.
July 15, 2026
·
3 min read
·
Angela Gabriel
Press Releases
Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches
July 7, 2026
·
7 min read
Insights
Fibrosis, IPF and the search for better therapies
In this episode of Denatured, you’ll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, co-founder and Chief Medical Officer of Calluna Pharma. We dive into IPF and fibrosis challenges, unpacking treatment hurdles, emerging targets, unmet needs and expansion paths beyond the lung.
May 7, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Background Check Anxiety: 7 Myths Ruining Your Job Search
April 10, 2026
·
1 min read
Alzheimer’s disease
Lilly bets up to $1B+ with AlzeCure in search for next Alzheimer’s act
The star of the licensing agreement, a small-molecule gamma-secretase modulator, will help buff Eli Lilly’s position in Alzheimer’s disease, currently headlined by its anti-amyloid antibody Kisunla.
June 10, 2026
·
2 min read
·
Tristan Manalac
Government
FDA uncertainty persists as search for Prasad successor at CBER drags on
The FDA is reportedly down to a handful of final candidates to lead CBER, with a potential selection expected in the coming month or two. For now, the appointment of acting director Katherine Szarama has not allayed the industry’s concerns.
May 5, 2026
·
2 min read
·
Tristan Manalac
Biotech Beach
Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
Equillium, Inc. (Nasdaq: EQ) today announced an update on multi-cytokine programs EQ101 in development for the treatment of alopecia areata, EQ102 in development for the treatment of celiac disease, and EQ302, a new orally delivered multi-cytokine inhibitor.
December 21, 2023
·
7 min read
1 of 3,460
Next
